Share Price and Basic Stock Data
Last Updated: February 9, 2026, 9:38 pm
| PEG Ratio | 5.74 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vinati Organics Ltd operates in the organic chemicals sector, specifically focusing on benzene-based products. As of the latest reporting, the company’s stock price stood at ₹1,496, and its market capitalization reached ₹15,513 Cr. The revenue from operations for the fiscal year ending in March 2025 was reported at ₹2,248 Cr, a notable increase from ₹2,066 Cr in the previous fiscal year. This growth trajectory is evident in the quarterly sales figures, where the company recorded sales of ₹517 Cr in December 2022, which fluctuated slightly in subsequent quarters, ultimately reaching ₹648 Cr in March 2025. The company has demonstrated resilience, managing to maintain a steady revenue growth despite fluctuating market conditions. The trailing twelve months (TTM) revenue stood at ₹2,259 Cr, reaffirming the company’s solid positioning within the sector, which is characterized by variable demand and pricing. Overall, Vinati Organics reflects a robust business model with commendable revenue trends in the organic chemicals space.
Profitability and Efficiency Metrics
Profitability for Vinati Organics is underscored by its operating profit margin (OPM), which stood at 30%, showcasing effective cost management and operational efficiency. The operating profit for the fiscal year ending March 2025 reached ₹587 Cr, an increase from ₹573 Cr in the previous fiscal year. The net profit also illustrated strength, recorded at ₹415 Cr for FY 2025, compared to ₹419 Cr in FY 2023. The company’s return on equity (ROE) was reported at 15.8%, while return on capital employed (ROCE) stood at 20.6%, indicating effective use of shareholder funds and capital. Furthermore, the net profit margin for FY 2025 was 18.02%, reflecting healthy profitability relative to sales. The interest coverage ratio (ICR) was exceptionally high at 1202.37x, indicating that the company can comfortably meet its interest obligations, which is a positive signal for investors. Overall, these metrics underscore Vinati Organics’ strong profitability and efficiency in operations.
Balance Sheet Strength and Financial Ratios
Vinati Organics boasts a robust balance sheet characterized by zero borrowings, demonstrating a strong financial position. The reserves have steadily increased, reported at ₹2,796 Cr for FY 2025, compared to ₹2,203 Cr in FY 2023. The total assets also saw a significant rise, reaching ₹3,263 Cr, indicating solid asset management and growth. The company’s current ratio stood at 3.31x, well above the typical sector benchmark, highlighting excellent liquidity. The price-to-book value (P/BV) ratio was recorded at 5.86x, suggesting that the stock may be trading at a premium relative to its book value, which is ₹269.36 per share. The company also reported an asset turnover ratio of 0.73, indicating efficient utilization of assets to generate revenue. With such strong financial metrics, Vinati Organics is well-positioned to navigate potential market challenges while maintaining growth.
Shareholding Pattern and Investor Confidence
The shareholding structure of Vinati Organics reflects strong promoter confidence, with promoters holding 74.29% of the equity as of March 2025. This stable ownership is complemented by foreign institutional investors (FIIs) holding 3.77% and domestic institutional investors (DIIs) at 9.55%. The public shareholding stood at 12.39%, indicating a healthy distribution among retail investors. The number of shareholders has seen a steady increase, rising to 85,005 by September 2025, up from 80,645 in December 2022. This growing base of shareholders suggests increasing investor interest and confidence in the company’s performance. Despite minor fluctuations in FII and DII holdings, the overall stability in promoter ownership is a strong indicator of long-term commitment to the company’s growth strategy. Investor confidence appears to be bolstered by the company’s consistent financial performance and positive market outlook.
Outlook, Risks, and Final Insight
Looking ahead, Vinati Organics is poised for continued growth, supported by its strong financial fundamentals and operational efficiency. However, risks do exist, including potential volatility in raw material prices and changing regulatory environments in the chemicals sector, which could impact profitability. The company’s reliance on benzene-based products may expose it to market fluctuations, necessitating diversification strategies. Additionally, while the absence of debt is a strength, it also presents a risk if the company seeks aggressive expansion, as it may need to consider leveraging options. Overall, Vinati Organics has a favorable outlook based on its solid performance metrics and operational strength, but it must remain vigilant about market dynamics to sustain its growth trajectory and shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Organic Chemicals Ltd | 207 Cr. | 30.9 | 45.0/22.4 | 152 | 0.00 % | 5.20 % | 21.6 % | 10.0 | |
| Vinati Organics Ltd | 16,097 Cr. | 1,552 | 2,040/1,412 | 33.7 | 287 | 0.48 % | 20.6 % | 15.8 % | 1.00 |
| Seya Industries Ltd | 45.1 Cr. | 17.0 | 25.3/12.6 | 309 | 0.00 % | 0.51 % | 0.77 % | 10.0 | |
| Industry Average | 8,152.00 Cr | 533.30 | 33.70 | 249.33 | 0.16% | 8.77% | 12.72% | 7.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 517 | 519 | 439 | 463 | 448 | 550 | 525 | 553 | 522 | 648 | 542 | 546 | 529 |
| Expenses | 369 | 372 | 338 | 358 | 333 | 400 | 400 | 419 | 379 | 465 | 376 | 368 | 368 |
| Operating Profit | 148 | 147 | 100 | 105 | 115 | 150 | 125 | 134 | 143 | 184 | 166 | 179 | 161 |
| OPM % | 29% | 28% | 23% | 23% | 26% | 27% | 24% | 24% | 27% | 28% | 31% | 33% | 30% |
| Other Income | 11 | 12 | 10 | 11 | 9 | 10 | 9 | 22 | 7 | 6 | 7 | 16 | 9 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 17 | 17 | 17 | 17 | 19 | 19 | 20 | 21 | 20 | 20 | 21 | 22 | 24 |
| Profit before tax | 142 | 142 | 93 | 97 | 103 | 140 | 114 | 136 | 129 | 169 | 151 | 173 | 145 |
| Tax % | 25% | 26% | 25% | 25% | 25% | 25% | 25% | 22% | 26% | 25% | 26% | 25% | 25% |
| Net Profit | 107 | 105 | 69 | 72 | 77 | 104 | 86 | 106 | 96 | 128 | 113 | 129 | 108 |
| EPS in Rs | 10.40 | 10.18 | 6.75 | 7.05 | 7.49 | 10.08 | 8.30 | 10.24 | 9.22 | 12.31 | 10.88 | 12.45 | 10.46 |
Last Updated: February 3, 2026, 3:46 pm
Below is a detailed analysis of the quarterly data for Vinati Organics Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 529.00 Cr.. The value appears to be declining and may need further review. It has decreased from 546.00 Cr. (Sep 2025) to 529.00 Cr., marking a decrease of 17.00 Cr..
- For Expenses, as of Dec 2025, the value is 368.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 368.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 161.00 Cr.. The value appears to be declining and may need further review. It has decreased from 179.00 Cr. (Sep 2025) to 161.00 Cr., marking a decrease of 18.00 Cr..
- For OPM %, as of Dec 2025, the value is 30.00%. The value appears to be declining and may need further review. It has decreased from 33.00% (Sep 2025) to 30.00%, marking a decrease of 3.00%.
- For Other Income, as of Dec 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Sep 2025) to 9.00 Cr., marking a decrease of 7.00 Cr..
- For Interest, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Sep 2025) to 24.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 173.00 Cr. (Sep 2025) to 145.00 Cr., marking a decrease of 28.00 Cr..
- For Tax %, as of Dec 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 25.00%.
- For Net Profit, as of Dec 2025, the value is 108.00 Cr.. The value appears to be declining and may need further review. It has decreased from 129.00 Cr. (Sep 2025) to 108.00 Cr., marking a decrease of 21.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 10.46. The value appears to be declining and may need further review. It has decreased from 12.45 (Sep 2025) to 10.46, marking a decrease of 1.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:25 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 696 | 772 | 631 | 641 | 730 | 1,128 | 1,029 | 954 | 1,616 | 2,066 | 1,900 | 2,248 | 2,259 |
| Expenses | 543 | 580 | 424 | 423 | 531 | 703 | 614 | 601 | 1,180 | 1,493 | 1,429 | 1,662 | 1,588 |
| Operating Profit | 153 | 192 | 207 | 218 | 198 | 425 | 415 | 353 | 435 | 573 | 471 | 587 | 671 |
| OPM % | 22% | 25% | 33% | 34% | 27% | 38% | 40% | 37% | 27% | 28% | 25% | 26% | 30% |
| Other Income | 9 | 9 | 6 | 12 | 31 | 30 | 45 | 26 | 61 | 52 | 39 | 44 | 36 |
| Interest | 18 | 10 | 8 | 3 | 2 | 2 | 2 | 1 | 2 | 3 | 5 | 2 | 1 |
| Depreciation | 15 | 18 | 19 | 22 | 23 | 27 | 33 | 43 | 45 | 59 | 73 | 81 | 83 |
| Profit before tax | 129 | 174 | 187 | 206 | 203 | 425 | 425 | 335 | 449 | 563 | 432 | 548 | 623 |
| Tax % | 33% | 33% | 29% | 32% | 29% | 34% | 21% | 20% | 23% | 26% | 25% | 24% | |
| Net Profit | 86 | 116 | 132 | 140 | 144 | 282 | 334 | 269 | 347 | 419 | 323 | 415 | 465 |
| EPS in Rs | 8.75 | 11.22 | 12.75 | 13.59 | 14.00 | 27.48 | 32.48 | 26.20 | 33.73 | 40.78 | 31.19 | 40.05 | 44.86 |
| Dividend Payout % | 17% | 16% | 16% | 2% | 16% | 13% | 17% | 23% | 19% | 17% | 22% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 34.88% | 13.79% | 6.06% | 2.86% | 95.83% | 18.44% | -19.46% | 29.00% | 20.75% | -22.91% | 28.48% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.09% | -7.73% | -3.20% | 92.98% | -77.39% | -37.90% | 48.46% | -8.25% | -43.66% | 51.39% |
Vinati Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 12% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 12% |
| 3 Years: | -9% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: February 1, 2026, 2:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 300 | 424 | 530 | 670 | 786 | 1,041 | 1,269 | 1,533 | 1,851 | 2,203 | 2,454 | 2,796 | 2,960 |
| Borrowings | 162 | 65 | 42 | 2 | 15 | 4 | 0 | 2 | 28 | 35 | 5 | 63 | 0 |
| Other Liabilities | 80 | 100 | 104 | 139 | 168 | 173 | 163 | 188 | 260 | 335 | 358 | 394 | 350 |
| Total Liabilities | 552 | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 | 3,320 |
| Fixed Assets | 304 | 327 | 382 | 468 | 457 | 475 | 751 | 757 | 874 | 1,159 | 1,330 | 1,382 | 1,341 |
| CWIP | 10 | 20 | 25 | 7 | 35 | 191 | 31 | 55 | 306 | 229 | 246 | 298 | 372 |
| Investments | 3 | 3 | 3 | 62 | 132 | 96 | 227 | 289 | 98 | 256 | 237 | 523 | 776 |
| Other Assets | 235 | 249 | 278 | 284 | 356 | 465 | 434 | 633 | 872 | 940 | 1,014 | 1,059 | 831 |
| Total Assets | 552 | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 | 3,320 |
Below is a detailed analysis of the balance sheet data for Vinati Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,960.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,796.00 Cr. (Mar 2025) to 2,960.00 Cr., marking an increase of 164.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 63.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 350.00 Cr.. The value appears to be improving (decreasing). It has decreased from 394.00 Cr. (Mar 2025) to 350.00 Cr., marking a decrease of 44.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,320.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,263.00 Cr. (Mar 2025) to 3,320.00 Cr., marking an increase of 57.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,341.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,382.00 Cr. (Mar 2025) to 1,341.00 Cr., marking a decrease of 41.00 Cr..
- For CWIP, as of Sep 2025, the value is 372.00 Cr.. The value appears strong and on an upward trend. It has increased from 298.00 Cr. (Mar 2025) to 372.00 Cr., marking an increase of 74.00 Cr..
- For Investments, as of Sep 2025, the value is 776.00 Cr.. The value appears strong and on an upward trend. It has increased from 523.00 Cr. (Mar 2025) to 776.00 Cr., marking an increase of 253.00 Cr..
- For Other Assets, as of Sep 2025, the value is 831.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,059.00 Cr. (Mar 2025) to 831.00 Cr., marking a decrease of 228.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,320.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,263.00 Cr. (Mar 2025) to 3,320.00 Cr., marking an increase of 57.00 Cr..
Notably, the Reserves (2,960.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -9.00 | 127.00 | 165.00 | 216.00 | 183.00 | 421.00 | 415.00 | 351.00 | 407.00 | 538.00 | 466.00 | 524.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 61 | 66 | 80 | 89 | 79 | 72 | 106 | 102 | 82 | 102 | 96 |
| Inventory Days | 41 | 44 | 55 | 79 | 79 | 64 | 79 | 115 | 85 | 79 | 72 | 66 |
| Days Payable | 12 | 17 | 28 | 40 | 61 | 37 | 47 | 62 | 52 | 41 | 36 | 43 |
| Cash Conversion Cycle | 89 | 87 | 94 | 119 | 107 | 106 | 104 | 158 | 136 | 120 | 137 | 119 |
| Working Capital Days | 45 | 58 | 60 | 118 | 113 | 111 | 97 | 138 | 144 | 109 | 140 | 107 |
| ROCE % | 30% | 38% | 36% | 33% | 28% | 46% | 37% | 24% | 26% | 27% | 19% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Flexi Cap Fund | 1,387,969 | 0.88 | 220.58 | N/A | N/A | N/A |
| Canara Robeco Large and Mid Cap Fund | 1,232,048 | 0.76 | 195.8 | N/A | N/A | N/A |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 774,862 | 0.8 | 123.14 | N/A | N/A | N/A |
| Canara Robeco Flexi Cap Fund | 718,956 | 0.83 | 114.26 | 711,456 | 2025-12-15 02:18:58 | 1.05% |
| HSBC Small Cap Fund | 622,492 | 0.62 | 98.93 | N/A | N/A | N/A |
| ICICI Prudential Multi Asset Fund | 603,410 | 0.12 | 95.89 | 594,254 | 2026-01-26 04:56:07 | 1.54% |
| Aditya Birla Sun Life Multi-Cap Fund | 521,879 | 1.24 | 82.94 | N/A | N/A | N/A |
| Canara Robeco ELSS Tax Saver Fund | 490,300 | 0.86 | 77.92 | 215,300 | 2025-11-03 10:07:01 | 127.73% |
| Canara Robeco Equity Hybrid Fund | 484,724 | 0.68 | 77.03 | 338,000 | 2025-11-03 10:07:01 | 43.41% |
| Quant Small Cap Fund | 362,211 | 0.19 | 57.56 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 39.09 | 31.15 | 44.56 | 33.72 | 26.20 |
| Diluted EPS (Rs.) | 39.09 | 31.15 | 44.56 | 33.72 | 26.20 |
| Cash EPS (Rs.) | 47.62 | 38.19 | 49.61 | 38.15 | 30.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 269.36 | 221.98 | 215.82 | 177.85 | 150.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 269.36 | 221.98 | 215.82 | 177.85 | 150.16 |
| Revenue From Operations / Share (Rs.) | 216.80 | 183.28 | 202.83 | 157.18 | 92.84 |
| PBDIT / Share (Rs.) | 60.29 | 49.05 | 64.98 | 48.16 | 36.81 |
| PBIT / Share (Rs.) | 51.76 | 42.02 | 59.92 | 43.73 | 32.64 |
| PBT / Share (Rs.) | 51.70 | 41.67 | 59.86 | 43.71 | 32.62 |
| Net Profit / Share (Rs.) | 39.08 | 31.15 | 44.56 | 33.72 | 26.20 |
| NP After MI And SOA / Share (Rs.) | 39.08 | 31.15 | 44.56 | 33.72 | 26.20 |
| PBDIT Margin (%) | 27.81 | 26.76 | 32.03 | 30.64 | 39.65 |
| PBIT Margin (%) | 23.87 | 22.92 | 29.54 | 27.82 | 35.15 |
| PBT Margin (%) | 23.84 | 22.73 | 29.51 | 27.80 | 35.13 |
| Net Profit Margin (%) | 18.02 | 16.99 | 21.96 | 21.45 | 28.22 |
| NP After MI And SOA Margin (%) | 18.02 | 16.99 | 21.96 | 21.45 | 28.22 |
| Return on Networth / Equity (%) | 14.50 | 14.03 | 20.64 | 18.96 | 17.44 |
| Return on Capital Employeed (%) | 18.09 | 16.61 | 26.46 | 23.38 | 20.61 |
| Return On Assets (%) | 12.35 | 11.37 | 17.98 | 16.58 | 15.53 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 0.73 | 0.70 | 0.89 | 0.84 | 0.60 |
| Current Ratio (X) | 3.31 | 4.53 | 4.52 | 4.64 | 6.15 |
| Quick Ratio (X) | 2.61 | 3.62 | 3.65 | 3.59 | 5.01 |
| Inventory Turnover Ratio (X) | 10.71 | 5.19 | 5.93 | 5.74 | 3.87 |
| Dividend Payout Ratio (NP) (%) | 17.90 | 22.27 | 14.58 | 17.79 | 1.90 |
| Dividend Payout Ratio (CP) (%) | 14.69 | 18.17 | 13.10 | 15.72 | 1.64 |
| Earning Retention Ratio (%) | 82.10 | 77.73 | 85.42 | 82.21 | 98.10 |
| Cash Earning Retention Ratio (%) | 85.31 | 81.83 | 86.90 | 84.28 | 98.36 |
| Interest Coverage Ratio (X) | 1202.37 | 140.04 | 1064.81 | 1913.39 | 1785.59 |
| Interest Coverage Ratio (Post Tax) (X) | 780.33 | 89.94 | 731.19 | 1340.85 | 1271.98 |
| Enterprise Value (Cr.) | 16441.23 | 15241.12 | 18575.21 | 20078.18 | 14384.14 |
| EV / Net Operating Revenue (X) | 7.31 | 8.02 | 8.91 | 12.43 | 15.07 |
| EV / EBITDA (X) | 26.30 | 29.97 | 27.81 | 40.56 | 38.02 |
| MarketCap / Net Operating Revenue (X) | 7.29 | 8.03 | 8.92 | 12.42 | 15.08 |
| Retention Ratios (%) | 82.09 | 77.72 | 85.41 | 82.20 | 98.09 |
| Price / BV (X) | 5.86 | 6.63 | 8.38 | 10.98 | 9.32 |
| Price / Net Operating Revenue (X) | 7.29 | 8.03 | 8.92 | 12.42 | 15.08 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
After reviewing the key financial ratios for Vinati Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 39.09. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.09, marking an increase of 7.94.
- For Diluted EPS (Rs.), as of Mar 25, the value is 39.09. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.09, marking an increase of 7.94.
- For Cash EPS (Rs.), as of Mar 25, the value is 47.62. This value is within the healthy range. It has increased from 38.19 (Mar 24) to 47.62, marking an increase of 9.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.36. It has increased from 221.98 (Mar 24) to 269.36, marking an increase of 47.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.36. It has increased from 221.98 (Mar 24) to 269.36, marking an increase of 47.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 216.80. It has increased from 183.28 (Mar 24) to 216.80, marking an increase of 33.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 60.29. This value is within the healthy range. It has increased from 49.05 (Mar 24) to 60.29, marking an increase of 11.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 51.76. This value is within the healthy range. It has increased from 42.02 (Mar 24) to 51.76, marking an increase of 9.74.
- For PBT / Share (Rs.), as of Mar 25, the value is 51.70. This value is within the healthy range. It has increased from 41.67 (Mar 24) to 51.70, marking an increase of 10.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 39.08. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.08, marking an increase of 7.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 39.08. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.08, marking an increase of 7.93.
- For PBDIT Margin (%), as of Mar 25, the value is 27.81. This value is within the healthy range. It has increased from 26.76 (Mar 24) to 27.81, marking an increase of 1.05.
- For PBIT Margin (%), as of Mar 25, the value is 23.87. This value exceeds the healthy maximum of 20. It has increased from 22.92 (Mar 24) to 23.87, marking an increase of 0.95.
- For PBT Margin (%), as of Mar 25, the value is 23.84. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 23.84, marking an increase of 1.11.
- For Net Profit Margin (%), as of Mar 25, the value is 18.02. This value exceeds the healthy maximum of 10. It has increased from 16.99 (Mar 24) to 18.02, marking an increase of 1.03.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.02. This value is within the healthy range. It has increased from 16.99 (Mar 24) to 18.02, marking an increase of 1.03.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.50. This value is below the healthy minimum of 15. It has increased from 14.03 (Mar 24) to 14.50, marking an increase of 0.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.09. This value is within the healthy range. It has increased from 16.61 (Mar 24) to 18.09, marking an increase of 1.48.
- For Return On Assets (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has increased from 11.37 (Mar 24) to 12.35, marking an increase of 0.98.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has increased from 0.70 (Mar 24) to 0.73, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 4.53 (Mar 24) to 3.31, marking a decrease of 1.22.
- For Quick Ratio (X), as of Mar 25, the value is 2.61. This value exceeds the healthy maximum of 2. It has decreased from 3.62 (Mar 24) to 2.61, marking a decrease of 1.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.71. This value exceeds the healthy maximum of 8. It has increased from 5.19 (Mar 24) to 10.71, marking an increase of 5.52.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.90. This value is below the healthy minimum of 20. It has decreased from 22.27 (Mar 24) to 17.90, marking a decrease of 4.37.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.69. This value is below the healthy minimum of 20. It has decreased from 18.17 (Mar 24) to 14.69, marking a decrease of 3.48.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.10. This value exceeds the healthy maximum of 70. It has increased from 77.73 (Mar 24) to 82.10, marking an increase of 4.37.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.31. This value exceeds the healthy maximum of 70. It has increased from 81.83 (Mar 24) to 85.31, marking an increase of 3.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1,202.37. This value is within the healthy range. It has increased from 140.04 (Mar 24) to 1,202.37, marking an increase of 1,062.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 780.33. This value is within the healthy range. It has increased from 89.94 (Mar 24) to 780.33, marking an increase of 690.39.
- For Enterprise Value (Cr.), as of Mar 25, the value is 16,441.23. It has increased from 15,241.12 (Mar 24) to 16,441.23, marking an increase of 1,200.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.31. This value exceeds the healthy maximum of 3. It has decreased from 8.02 (Mar 24) to 7.31, marking a decrease of 0.71.
- For EV / EBITDA (X), as of Mar 25, the value is 26.30. This value exceeds the healthy maximum of 15. It has decreased from 29.97 (Mar 24) to 26.30, marking a decrease of 3.67.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 8.03 (Mar 24) to 7.29, marking a decrease of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 82.09. This value exceeds the healthy maximum of 70. It has increased from 77.72 (Mar 24) to 82.09, marking an increase of 4.37.
- For Price / BV (X), as of Mar 25, the value is 5.86. This value exceeds the healthy maximum of 3. It has decreased from 6.63 (Mar 24) to 5.86, marking a decrease of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 8.03 (Mar 24) to 7.29, marking a decrease of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vinati Organics Ltd:
- Net Profit Margin: 18.02%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.09% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.5% (Industry Average ROE: 12.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 780.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.61
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 33.7 (Industry average Stock P/E: 33.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.02%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Benzene Based | B-12 & B-13/1, MIDC Industrial Area, Raigad District Maharashtra 402309 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vinod Saraf | Chairman |
| Ms. Vinati Saraf Mutreja | Managing Director & CEO |
| Mr. Amit Thanawala | Whole Time Director |
| Prof. M Lakshmi Kantam | Independent Director |
| Mr. J C Laddha | Independent Director |
| Ms. Viral Saraf Mittal | Director - Corporate Strategy |
| Mrs. Mona Bhide | Independent Director |
| Dr. Prashant Barve | Independent Director |
FAQ
What is the intrinsic value of Vinati Organics Ltd?
Vinati Organics Ltd's intrinsic value (as of 10 February 2026) is ₹1300.49 which is 16.21% lower the current market price of ₹1,552.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹16,097 Cr. market cap, FY2025-2026 high/low of ₹2,040/1,412, reserves of ₹2,960 Cr, and liabilities of ₹3,320 Cr.
What is the Market Cap of Vinati Organics Ltd?
The Market Cap of Vinati Organics Ltd is 16,097 Cr..
What is the current Stock Price of Vinati Organics Ltd as on 10 February 2026?
The current stock price of Vinati Organics Ltd as on 10 February 2026 is ₹1,552.
What is the High / Low of Vinati Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vinati Organics Ltd stocks is ₹2,040/1,412.
What is the Stock P/E of Vinati Organics Ltd?
The Stock P/E of Vinati Organics Ltd is 33.7.
What is the Book Value of Vinati Organics Ltd?
The Book Value of Vinati Organics Ltd is 287.
What is the Dividend Yield of Vinati Organics Ltd?
The Dividend Yield of Vinati Organics Ltd is 0.48 %.
What is the ROCE of Vinati Organics Ltd?
The ROCE of Vinati Organics Ltd is 20.6 %.
What is the ROE of Vinati Organics Ltd?
The ROE of Vinati Organics Ltd is 15.8 %.
What is the Face Value of Vinati Organics Ltd?
The Face Value of Vinati Organics Ltd is 1.00.